Autosomal dominant combined immunodeficiency due to partial IL6ST deficiency: A Patient Guide
At a Glance
Autosomal dominant partial IL6ST deficiency is a rare inherited immune disorder that can cause repeated skin and lung infections, eczema, dental and joint changes, and a muted fever response during serious illness. Preventive treatment and regular lung monitoring help limit lasting damage.
Autosomal dominant (AD) partial IL6ST deficiency is an exceptionally rare genetic condition that belongs to a group of disorders known as Hyper-IgE syndromes (HIES). At its core, this diagnosis means that a specific signaling hub in your cells, called the GP130 receptor, is not working at full capacity [1]. Because this receptor acts like a universal adapter for many important immune and growth signals, its partial failure creates a unique pattern of health challenges that affect the skin, the immune system, and the skeletal system [1][2].
The biological consequence of this deficiency is a “muffled” immune response. Specifically, the body struggles to hear the messages sent by cytokines like IL-6 and IL-11, which are thought to contribute to triggering fevers and coordinating bone development [1][3]. This quiet signaling explains why you may experience recurrent skin abscesses and lung infections (pneumonia). Because your internal “alarm” is dampened, you might not always develop the high fevers or typical lab markers that usually signal a serious illness [1][4]. However, it is crucial to remember that a normal temperature or normal lab results do not rule out a serious infection.
Alongside these infections, some people deal with severe eczema and distinct physical features, such as baby teeth that do not fall out on their own (retained deciduous teeth) and extra-flexible joints [1][5].
One of the most striking features of this condition is how much it varies from person to person. Even within the same family, one individual might face significant health hurdles while another has only mild symptoms [1][6]. Because this is an autosomal dominant condition, a person with this diagnosis has a 50% chance of passing the genetic variant to each biological child, making genetic counseling an important part of family planning.
The primary long-term goal is the preservation of lung health. Over time, repeated infections can lead to structural changes such as bronchiectasis (scarred airways) or air-filled cysts called pneumatoceles, which can become homes for opportunistic molds like Aspergillus [7][8].
Living well with AD-IL6ST deficiency requires a shift toward a proactive, “prevention-first” mindset. Management relies on a dedicated, individualized care team and the closely monitored use of preventative (prophylactic) treatments to stop infections before they can cause lasting damage [9][10]. While the rarity of the diagnosis can feel overwhelming, understanding the specific nature of your immune system allows you and your doctors to stay ahead of the condition, ensuring that you receive the right support at the right time [11].
In this guide
6 chapters
Understanding Your Diagnosis: Validation, Orientation, and Urgent Signs
Learn what autosomal dominant partial IL6ST deficiency means, how it affects immunity, which symptoms need attention, and when to seek urgent medical care.
Symptoms and Differential Diagnosis: What to Expect and How It Compares
Learn AD-IL6ST deficiency symptoms, how it differs from other Hyper-IgE syndromes, and why genetic testing matters when fever or CRP is low during infection.
The Biology of Your Diagnosis: How the IL6ST Gene and GP130 Receptor Work
Learn how partial IL6ST deficiency disrupts GP130 signaling, affects IL-6 and IL-11, and may explain infection, dental, and skeletal features in this condition.
Understanding Your Lab Results and Diagnosis
Learn how partial IL6ST deficiency is diagnosed using genetic testing and lab clues such as IgE, eosinophils, memory B cells, CRP, and STAT3 functional assays.
Standard of Care Treatment and Daily Management
Learn how to manage partial IL6ST deficiency with antibiotic prophylaxis, immunoglobulin replacement, skin and lung care, and specialist treatment options.
Long-Term Monitoring, Surveillance, and Building Your Care Team
Learn how to monitor AD partial IL6ST deficiency, including lung tests, bone and dental checks, specialist care, Aspergillus watch, and scan anxiety support.
Common questions in this guide
What is autosomal dominant partial IL6ST deficiency?
Can I have a serious infection without a high fever?
What symptoms can partial IL6ST deficiency cause?
How can this condition affect the lungs over time?
What treatments can help prevent infections?
What does this diagnosis mean for my future children?
Get notified when new evidence is published on Autosomal dominant combined immunodeficiency due to partial IL6ST deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
Béziat V, Tavernier SJ, Chen YH, et al.
The Journal of experimental medicine 2020; (217(6)) doi:10.1084/jem.20191804.
PMID: 32207811 - 2
A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.
Schwerd T, Twigg SRF, Aschenbrenner D, et al.
The Journal of experimental medicine 2017; (214(9)):2547-2562 doi:10.1084/jem.20161810.
PMID: 28747427 - 3
Hyper-IgE syndrome, 2021 update.
Minegishi Y
Allergology international : official journal of the Japanese Society of Allergology 2021; (70(4)):407-414 doi:10.1016/j.alit.2021.07.007.
PMID: 34419355 - 4
Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH, Zastrow DB, Metcalfe RD, et al.
The Journal of allergy and clinical immunology 2021; (148(2)):585-598 doi:10.1016/j.jaci.2021.02.044.
PMID: 33771552 - 5
The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH, van Zon S, Adams A, et al.
Journal of clinical immunology 2023; (44(1)):30 doi:10.1007/s10875-023-01603-7.
PMID: 38133879 - 6
New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T, Materna M, Riccio O, et al.
Journal of clinical immunology 2023; (43(7)):1566-1580 doi:10.1007/s10875-023-01517-4.
PMID: 37273120 - 7
Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome.
Mahdaviani SA, Ghadimi S, Fallahi M, et al.
BMC surgery 2023; (23(1)):289 doi:10.1186/s12893-023-02193-2.
PMID: 37741967 - 8
Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review.
Xie T, Xu N, Zhao H, et al.
Orphanet journal of rare diseases 2025; (20(1)):270 doi:10.1186/s13023-025-03749-6.
PMID: 40462219 - 9
Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.
Gernez Y, Freeman AF, Holland SM, et al.
The journal of allergy and clinical immunology. In practice 2018; (6(3)):996-1001 doi:10.1016/j.jaip.2017.06.041.
PMID: 28939137 - 10
Hemoptysis in a Patient with Elevated Immunoglobulin E.
Gernez Y, Tsuang A, Smith TD, et al.
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1054-1058 doi:10.1016/j.jaip.2016.08.003.
PMID: 27693026 - 11
Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.
Freeman AF, Wang C, Urban A, et al.
The Journal of allergy and clinical immunology 2026; (158(2)):569-581 doi:10.1016/j.jaci.2026.04.012.
PMID: 42061468
This page is for informational purposes only and does not constitute medical advice about IL6ST deficiency. Your healthcare team should tailor infection monitoring, preventive treatment, and genetic counseling to your situation.